Wat is de prijs voor Zoetis Inc. (ZTS)

Het prijs van Zoetis Inc. (ZTS) is $71.46

Wat is de marktkapitalisatie voor Zoetis Inc. (ZTS)

Marktkapitalisatie voorZoetis Inc. (ZTS) is $29.96B

Zoetis Inc. (ZTS) Dividenden

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Jaar	Dividend (aangepast voor aandelensplitsingen)	Wijzigen
2026 (TTM)	$0.53	-73.50%
2025	$2.00	15.74%
2024	$1.73	15.20%
2023	$1.50	15.38%
2022	$1.30	30.00%
2021	$1.00	25.00%
2020	$0.8	21.95%
2019	$0.656	30.16%
2018	$0.504	20.00%
2017	$0.42	10.53%
2016	$0.38	14.46%
2015	$0.332	15.28%
2014	$0.288	47.69%
2013	$0.195	0.00%

Jaar

Dividend (aangepast voor aandelensplitsingen)

Wijzigen

2026 (TTM)

$0.53

-73.50%

2025

$2.00

15.74%

2024

$1.73

15.20%

2023

$1.50

15.38%

2022

$1.30

30.00%

2021

$1.00

25.00%

2020

$0.8

21.95%

2019

$0.656

30.16%

2018

$0.504

20.00%

2017

$0.42

10.53%

2016

$0.38

14.46%

2015

$0.332

15.28%

2014

$0.288

47.69%

2013

$0.195

0.00%

Jaar	Dividend	Wijzigen
2026 (TTM)	$0.53	-73.50%
2025	$2.00	15.74%
2024	$1.73	15.20%
2023	$1.50	15.38%
2022	$1.30	30.00%
2021	$1.00	25.00%
2020	$0.8	21.95%
2019	$0.656	30.16%
2018	$0.504	20.00%
2017	$0.42	10.53%
2016	$0.38	14.46%
2015	$0.332	15.28%
2014	$0.288	47.69%
2013	$0.195	0.00%